Seminars in oncology
Journal
Overview
publication venue for
-
Gastric mucosa-associated lymphoid tissue lymphoma.
2010
-
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab..
49.
2022
-
Commentary: Somatostatin analogs-How we choose, and why..
44.
2017
-
The future of clinical cancer genomics..
43.
2016
-
Health disparities and the cancer survivor..
40.
2013
-
Renal and pulmonary late effects of cancer therapy..
40.
2013
-
Quantitative ultrasound in cancer imaging..
38.
2011
-
Readers' responses to "Breast cancer with positive sentinel lymph node: now what?"..
37.
2010
-
Whither TNM?.
37.
2010
-
Janus kinase mutations..
36.
2009
-
Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard..
34.
2007
-
Are cancers of the esophagus, gastroesophageal junction, and cardia one disease, two, or several?.
31.
2004
-
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone..
30.
2003
-
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab)..
29.
2002
-
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: an international update..
28.
2001
-
Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer..
26.
1999
-
A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report..
24.
1997
-
Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer..
24.
1997
-
Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team..
24.
1997
-
Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancer..
24.
1997
-
Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group..
23.
1996
-
Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience..
23.
1996
-
Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes..
22.
1995
-
Brachytherapy and hyperthermia for malignant astrocytomas..
21.
1994
-
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?.
19.
1992
-
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience..
19.
1992
-
A phase II pilot trial of high-dose hydroxyurea in chronic myelogenous leukemia..
19.
1992
-
Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience..
19.
1992
-
The European Organization for Research and Treatment of Cancer experience with teniposide: preliminary results of a randomized study in non-small cell lung cancer..
19.
1992
-
Can we combine available data to evaluate the effects of neoadjuvant chemotherapy for invasive bladder cancer?.
17.
1990
-
High-dose thiotepa alone and in combination regimens with bone marrow support..
17.
1990
-
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center..
16.
1989
-
The European Organization for Research and Treatment of Cancer (EORTC) trials of new agents for advanced non-small cell lung cancer..
15.
1988
-
Identification and management of poor risk patients with germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience..
15.
1988
-
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation..
14.
1987
-
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B..
14.
1987
-
Hairy cell leukemia: a model for studying the B cell family of diseases..
13.
1986
-
Medical oncology manpower training: a position statement of the American Society of Clinical Oncology..
12.
1985
-
Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation..
12.
1985
-
Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I study..
12.
1985
-
The diagnosis of gastric cancer..
12.
1985
-
Nutritional support of the patient with esophageal cancer..
11.
1984
-
Indications for surgery for intrathoracic metastases in testicular carcinoma..
6.
1979
-
External radiotherapy of ovarian cancer: standard approaches and new frontiers..
2.
1975
-
Introduction: the 2008 European society for medical oncology international symposium on sarcomas and gastrointestinal stromal tumors..
36.
2009
-
Renal cell carcinoma: progress against an elusive tumor..
27.
2000
-
Primary chemotherapy for breast cancer: hope or hype?.
25.
1998
-
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
2003
-
New Approaches to the Treatment of Cancer-Related Anemia. Symposium proceedings. New York, October 23, 1993.
1994
-
Cancer in older adults: the oncologist's bread and butter..
35.
2008
-
The evolution of bladder cancer treatment: improvements in clinical management, enhanced clinical outcomes, and targeting newly identified molecular alterations..
34.
2007
-
Optimizing cancer chemotherapy and hormonal therapy: the key role of supportive agents. Introduction..
31.
2004
-
Esophageal cancer..
21.
1994
-
Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
2018
-
Controversies in multiple myeloma: Evidence-based update.
2016
-
ASCO Plenary Sessions: impact, legacy, future.
2016
-
Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.
2015
-
Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists.
2015
-
Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma.
2014
-
Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer.
2010
-
Clinical update: novel targets in gynecologic malignancies.
2004
-
COX-2 inhibition in upper aerodigestive tract tumors.
2004
-
Recommendations of follow-up after treatment of germ cell tumors.
2003
-
A clinical and scientific overview of tositumomab and iodine I 131 tositumomab.
2003
-
Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: review of the literature and future directions.
2003
-
Gallium nitrate in multiple myeloma: prolonged survival in a cohort of patients with advanced-stage disease.
2003
-
The effects of gallium nitrate on bone resorption.
2003
-
Targeting lethal minimal residual disease in small cell lung cancer.
2003
-
Trastuzumab in the treatment of non-small cell lung cancer.
2002
-
Adjuvant therapy of colon cancer.
2001
-
Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: a review of two phase III trials.
2001
-
Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy.
2000
-
Gastrointestinal emergencies in the critically ill cancer patient.
2000
-
Infectious complications in the critically ill patient with cancer.
2000
-
Metabolic emergencies in the cancer patient.
2000
-
Orthopedic emergencies in cancer patients.
2000
-
Respiratory emergencies.
2000
-
Urologic emergencies in the cancer patient.
2000
-
Contemporary approach to the classification of renal epithelial tumors.
2000
-
Novel investigative approaches for advanced renal cell carcinoma.
2000
-
Renal cell carcinoma: presentation, staging, and surgical treatment.
2000
-
Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
1999
-
Hepatic arterial chemotherapy in metastatic colorectal patients.
1999
-
Positron emission tomography imaging of colorectal cancer.
1999
-
Screening and surveillance for colorectal cancer.
1999
-
Lymphomas of the breast: pathology and clinical behavior.
1999
-
Primary CNS lymphoma.
1999
-
Gemcitabine plus taxane combinations in non-small cell lung cancer.
1999
-
Implementation of disease management guidelines in patients with advanced ovarian cancer.
1999
-
An update on European randomized studies in non-small cell lung cancer.
1998
-
B-cell development and maturation.
1998
-
Gemcitabine and paclitaxel combinations in non-small cell lung cancer.
1998
-
The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery.
1998
-
Breast-conserving surgery in the neoadjuvant setting.
1998
-
Management of malignant germ cell tumors of the ovary.
1998
-
Poor prognosis germ cell tumors: current status and future directions.
1998
-
Role of surgery in management of germ cell tumor.
1998
-
Therapy for good risk germ cell tumors.
1998
-
Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
1997
-
Adjuvant and neoadjuvant therapy for gastric cancer.
1996
-
Surgery for gastric cancer: the American view.
1996
-
Chemotherapy for advanced breast cancer: a current perspective.
1996
-
Adjuvant chemotherapy for patients with stage II nonseminomatous testis cancer.
1995
-
Adjuvant therapy of upper gastrointestinal tract cancers.
1995
-
Treatment of chronic myelogenous leukemia.
1995
-
Psycho-oncology: depression, anxiety, delirium.
1994
-
Advances in imaging.
1994
-
Bone metastases: improving the therapeutic index.
1994
-
Current status of monoclonal antibodies for imaging and therapy of prostate cancer.
1994
-
Methodological issues in studies of the treatment, diagnosis, and etiology of prostate cancer.
1994
-
Prostate cancer: improving the therapeutic index.
1994
-
The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate.
1994
-
Combined modality therapy in the treatment of esophageal cancer.
1994
-
Current approaches to metastatic colorectal cancer.
1994
-
The molecular basis for cellular transformation: implications for esophageal carcinogenesis.
1994
-
The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
1994
-
Immunophenotypic and immunogenotypic approaches useful in distinguishing benign and malignant lymphoid proliferations.
1993
-
Modulation of fluorouracil by N-(phosphonacetyl)-L-asparate: a review.
1992
-
Review of regional therapy of liver metastases in colorectal cancer.
1992
-
Cancer chemotherapy in the elderly.
1989
-
Corticosteroid therapy in patients with cerebral tumors: benefits, mechanisms, problems, practicalities.
1975
-
IO-IO vs IO-TKI efficacy in metastatic kidney cancer patients: A structured systematic review over time.
2022
-
Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials.
2021
-
Implications of reactive oxygen species on cancer formation and its treatment.
2021
-
Management of hormone receptor-positive, HER2-negative early breast cancer.
2020
-
A 46-Year-Old Asian Woman With Liver Mass.
2015
-
Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?
2013
-
The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas.
2013
-
Other targetable sarcomas.
2009
-
Sarcomas with spindle cell morphology.
2009
-
The molecular basis of melanomagenesis and the metastatic phenotype.
2007
-
CD22-directed monoclonal antibody therapy for lymphoma.
2003
-
Development of the epidermal growth factor receptor inhibitor OSI-774.
2003
-
Pharmacokinetics and pharmacodynamics: maximizing the clinical potential of Erlotinib (Tarceva).
2003
-
Angiogenesis inhibitors in clinical development for lung cancer.
2002
-
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).
2002
-
New prognostic factors for breast cancer recurrence.
2001
-
Neurologic emergencies in the cancer patient.
2000
-
Evolving concepts in the systemic drug therapy of breast cancer.
1997
-
Neoadjuvant and adjuvant chemotherapy in locally advanced bladder cancer.
1996
-
Adjuvant drug therapy for operable breast cancer.
1996
-
Women's psychological reactions to breast cancer.
1996
-
Salvage chemotherapy of breast cancer.
1994
-
High-intensity chemotherapy with peripheral blood progenitor cell support.
1994
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)